Journal of Vaccines and Immunology Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesYes
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    Merghoub Taha
    Associate Biologist
    Memorial Sloan Kettering Cancer Center
    USA
    MerghouT@mskcc.org
    JVI

    Research Interest: Pathogenesis and Treatment of Melanoma, and in Part are directed at Developing Tools to Study Melanoma.

    More Info.
    Regis Sodoyer
    Technology Research Institute Bioaster
    France
    regis.sodoyer@bioaster.org
    JVI

    Research Interest: Plant biotechnology, Regulation of expression by anti-messengers & ribozymes, Systems Biology.

    More Info.
    Ali Azizi
    Professor
    University of Ontario Institute of Technology
    Canada
    Ali.Azizi@sanofipasteur.com
    JVI

    Research Interest: Conduct several molecular biology and genomic assays including Sequencing, Cloning, RT-PCR, Southern blot, Northern blot, and Immunostaining.

    More Info.
    Jing Li
    Deputy Director and Professor
    Chinese Academy of Sciences
    China
    liuwj@im.ac.cn
    JVI

    Research Interest: Molecular biology of viruses, the interactions of viruses with host cells, the pathogenesis of viral diseases, the post-translational modification of viral proteins, and mechanisms of host defense. The research works are designed to increase fundamental knowledge as well as to facilitate the development of new approaches to control of viral infection.

    More Info.
    David Allen Reardon
    Professor
    Cancer Institute
    Harvard Cancer Center
    USA
    david_reardon@dfci.harvard.edu
    JVI

    Research Interest: Innovative Clinical Therapeutic Agents To Improve Cure Rates In Patients With Brain And Spinal Tumors, With Particular Focus On Immunotherapeutics As Well As Molecular-Targeting Agents, Anti-Angiogenic Reagents, Cytotoxins And Other Biologically-Based Therapies.

    More Info.
    Simona di Francesco
    Director
    Department of Urological, Biomedical and Traslational Sciences
    Nicolaus Copernicus University
    Poland
    docveronica@gmail.com
    JVI

    Research Interest: Endocrine and metabolic diseases in prostate cancer, bone metabolism, renal function, and immune structure in prostate cancer.

    More Info.
    Vincent C Lombardi
    Assistant Professor
    University of Nevada
    USA
    vlombardi@medicine.nevada.edu
    JVI

    Research Interest: Virology/Microbiology, Biochemistry, Clinical Diagnostics, Molecular Biology, Protein Chemistry.

    More Info.
    Robert Amato
    Professor and Director
    Department of Oncology
    USA
    Robert.Amato@uth.tmc.edu
    JVI

    Research Interest: Genitourinary Cancer

    More Info.
    Pele Choi-Sing Chong
    Founder of Vaccine Research and Development Center
    National Institute of Infectious Diseases and Vaccinology
    Taiwan
    pelechong@nhri.org.tw
    JVI

    Research Interest: Protein Engineering, Adjuvant and Vaccine Delivery Systems, Vaccinology, cGMP Quality Management, Immunology.

    More Info.
    Kuo C SHENG
    Research Fellow
    Griffith University
    Australia
    kuosheng@mail.com
    JVI

    Research Interest: Cancer immunology, vaccines, cancer, antigen-presenting cells and viral immunology.

    More Info.
    Wayne Grant Carter
    Division of Medical Sciences & Graduate Entry Medicine
    University of Nottingham
    UK
    Wayne.Carter@nottingham.ac.uk
    JVI

    Research Interest: Research interests are varied and include detection and utilisation of novel biomarkers of toxicological exposure.

    More Info.
    Ernesto Oviedo-Ortas
    Clinical Sciences Expert
    Novartis Vaccines and Diagnostics
    Italy
    ernesto.oviedo-orta@novartis.com
    JVI

    Research Interest: Clinical Immunology.

    More Info.
    Julie Bouckaert
    Researcher
    Computational Molecular Systems Biology
    Lille University of Science and Technology
    France
    julie.bouckaert@univ-lille1.fr
    JVI

    Research Interest: Structure-to-function relationships of microbial lectins Structural study of multivalent protein-carbohydrate interactions Analysis of differential glycosylation and bacterial infection pathology during metabolic imbalance Structure-based design of anti-bacterial and anti-fungal drugs.

    More Info.
    Andrea Poscia
    Public Health Institute
    Catholic University of Sacred Heart of Rome
    Italy
    andreaposcia83@gmail.com
    JVI

    Research Interest: HTA and to new communication strategies with people about vaccination, especially in consideration of the rising phenomena of anti-vaccination movements.

    More Info.
    Bing Ni
    Professor
    Institute of Immunology
    PLA Third Military Medical University
    China
    nibingxi@yahoo.com
    JVI

    Research Interest: Epigenetic regulation of virus or autoimmune diseases on host immune cells such as Treg, Th17 and innate lymphoid cells (ILCs).

    More Info.
    View more
    mendeley

    Study of adverse events following 2018 sub-national yellow fever vaccination in Ghana

    DOI Logo 10.17352/jvi.000055

    Published On: February 25, 2023 | Pages: 006 - 014

    Author(s): Douglas Adu-Fokuo, Feng Cheng*, Emily Yin and Elizabeth Giwa
    Abstract View Full Article View
    mendeley

    Alopecia areata

    DOI Logo 10.17352/jvi.000054

    Published On: February 21, 2023 | Pages: 001 - 005

    Author(s): Chieh Chen*

    ORCID Logo  0000-0001-5784-9855

    Abstract View Full Article View
    mendeley

    Effect of a third booster dose of COVID-19 mRNA vaccine in patients with haematological cancer after the initial two-dose vaccination - a single centre report

    DOI Logo 10.17352/jvi.000052

    Published On: August 08, 2022 | Pages: 029 - 032

    Author(s): Šušol Ondrej, Šušolová Barbora and Hájek Roman*
    Abstract View Full Article View
    mendeley

    Adult-onset Still’s disease complicated with macrophage activation syndrome: A case report

    DOI Logo 10.17352/jvi.000051

    Published On: July 23, 2022 | Pages: 023 - 028

    Author(s): MNSK Perera* and A Gunapala
    Abstract View Full Article View    
    mendeley

    Role of plant-derived natural compounds in macrophage polarization

    DOI Logo 10.17352/jvi.000050

    Published On: July 08, 2022 | Pages: 014 - 022

    Author(s): KP Mishra*, Jyotsana Bakshi, Mrinalini Singh, Deepika Saraswat, Lilly Ganju and Rajeev Varshney
    Abstract View Full Article View    
    mendeley

    Vaccines: Origin and evolution throughout history

    DOI Logo 10.17352/jvi.000049

    Published On: May 05, 2022 | Pages: 004 - 013

    Author(s): Maria de los Santos Onate Tenorio*, Maria Perez Eslava and Antonio Onate Tenorio
    Abstract View Full Article View    
    mendeley

    Changing seroprevalence to SARS-CoV-2 in health care workers during COVID-19 pandemic

    DOI Logo 10.17352/jvi.000048

    Published On: March 26, 2022 | Pages: 001 - 003

    Author(s): VK Sashindran, Abdul Raheem Sheikh and Sunita D Patil*
    Abstract View Full Article View    
    mendeley

    Nano-chemistry and Bio-conjugation with perspectives on the design of Nano-Immune platforms, vaccines and new combinatorial treatments

    DOI Logo 10.17352/jvi.000047

    Published On: December 13, 2021 | Pages: 049 - 056

    Author(s): Luna R Gomez Palacios, Sofia Martinez, Cecilia Tettamanti, Daniela Quinteros and A Guillermo Bracamonte*
    Abstract View Full Article View    
    mendeley

    Immunogenicity and safety of inactivated Influenza Split-Virion vaccine administered via a Transdermal Microneedle System

    DOI Logo 10.17352/jvi.000046

    Published On: December 13, 2021 | Pages: 041 - 048

    Author(s): Mahmoud Ameri*, Hayley Lewis and Joe Nguyen
    Abstract View Full Article View    
    mendeley

    Japanese Encephalitis (JE): A curse for people living in Uttar Pradesh, India

    DOI Logo 10.17352/jvi.000045

    Published On: October 04, 2021 | Pages: 036 - 040

    Author(s): Jay Prakash Patel*, Kusum Verma and Vijeta Singh
    Abstract View Full Article View    

     

    Clients' voices

    Readmore

    Indexing/Archiving

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on JVI

    Help ? Google Reviews 11